Physician profile
Ian B Hoffman
NPI 1558494773
$2,615.26
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,199 · 2020: $534 · 2021: $882.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $836.74 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $670.61 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $356.33 | 2019-2021 | |
| Insmed, INC. | $169.18 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $128.79 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $59.86 | 2021 | |
| Mallinckrodt Enterprises LLC | $50.86 | 2019 | |
| Grifols USA, LLC | $50.05 | 2019-2020 | |
| Genentech USA, INC. | $45.94 | 2019 | |
| Biomerieux INC | $26.74 | 2019 | |
| Abbvie INC. | $25.12 | 2021 | |
| Gilead Sciences, INC. | $22.02 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $21.53 | 2021 | |
| Genzyme Corporation | $20.77 | 2021 | |
| Allergan, INC. | $20.02 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $18.88 | 2020 | |
| Sobi, INC | $17.81 | 2019 | |
| Sanofi Pasteur INC. | $17.67 | 2020 | |
| Sunovion Pharmaceuticals INC. | $16.68 | 2019 | |
| Mylan Specialty L.P. | $14.61 | 2019 | |
| Inogen, INC. | $13.00 | 2019 | |
| Ucb, INC. | $12.05 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.